Filter News
Area of Research
- (-) Nuclear Science and Technology (11)
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Environment (50)
- Building Technologies (1)
- Clean Energy (60)
- Climate and Environmental Systems (1)
- Computational Biology (2)
- Computational Engineering (3)
- Computer Science (15)
- Fusion and Fission (4)
- Fusion Energy (2)
- Isotopes (26)
- Materials (74)
- Materials for Computing (17)
- Mathematics (1)
- National Security (37)
- Neutron Science (26)
- Quantum information Science (8)
- Sensors and Controls (1)
- Supercomputing (107)
News Topics
- (-) Biomedical (2)
- (-) Computer Science (2)
- (-) Cybersecurity (1)
- (-) Isotopes (5)
- (-) Transformational Challenge Reactor (3)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (11)
- Bioenergy (1)
- Coronavirus (1)
- Decarbonization (1)
- Environment (1)
- Fusion (8)
- Materials Science (3)
- Molten Salt (4)
- Neutron Science (5)
- Nuclear Energy (36)
- Physics (2)
- Space Exploration (5)
- Sustainable Energy (1)
Media Contacts
![Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227. Radiochemical technicians David Denton and Karen Murphy use hot cell manipulators at Oak Ridge National Laboratory during the production of actinium-227.](/sites/default/files/styles/list_page_thumbnail/public/2016-P07827%5B1%5D.jpg?itok=yJbnFQLU)
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.